Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...

HYDERABAD: With approximately a 150% increase in Hepatitis B cases and a 100% increase in Hepatitis C cases, Telangana has ...

Assembly Biosciences (ASMB) stock gains on interim data from a Phase 1 trial for its hepatitis B treatment ABI-4334 developed ...

As the Hepatitis B Virus (HBV) spreads across Nigeria, drug merchants are selling untested alternative medicines to patients, ...

In 2023, there were an estimated 68,890 people living with hepatitis C in Australia, down 58% from 162,590 at the end of 2015 ...

Local Hepatitis Elimination and Prevention Programme (LHEAP) and Gulf Care Hospital (GCH), a large private hospital, have ...

Kochi: A major hepatitis A outbreak was reported from Kalamassery. The affected areas are Peringazha, HMT Estate and Kurupra, ...

Many people have been cured of hepatitis C, something that was once viewed as a death sentence, but it has yet to make a big ...

Hepatitis is inflammation of the liver. Though it is most often caused by one of five different viruses (hepatitis A, B, C, D, and E), there are also nonviral causes ...

When news broke in 2014 that hepatitis C, a viral disease affecting the liver, could be cured thanks to a new class of direct-acting antiviral drugs, many began to wonder how soon it would be before ...

An international team of virologists, mammalian ecologists and zoologists has uncovered the evolutionary origins of the ...

Discover how the breakthrough HepB-CpG vaccine Heplisav-B offers up to 99 protection for people with HIV outperforming older ...